Profile
Anthony R.
DiSanto is currently the Vice President of Drug Development at Alamo Pharmaceuticals LLC and the President of AAAgent Services LLC.
He previously worked as a Vice President at The Upjohn Co. He received his undergraduate degree from Philadelphia University and his graduate degree from the University of Michigan.
Anthony DiSanto active positions
| Companies | Position | Start |
|---|---|---|
Alamo Pharmaceuticals LLC
 Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Corporate Officer/Principal | - |
Former positions of Anthony DiSanto
| Companies | Position | End |
|---|---|---|
| The Upjohn Co. | Corporate Officer/Principal | - |
Training of Anthony DiSanto
| University of Michigan | Graduate Degree |
| Philadelphia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Alamo Pharmaceuticals LLC
Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Health Technology |
| The Upjohn Co. | Health Technology |
- Stock Market
- Insiders
- Anthony DiSanto
